80 results
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
17 Apr 24
Departure of Directors or Certain Officers
4:23pm
travel may be approved under the following circumstances:
Required to accommodate a disability or special medical need (requires proof
from a medical … .
Required to accommodate a disability or special medical need.
An overall savings (subsistence costs, overtime, lost productivity time) compared
8-K
OCUP
Ocuphire Pharma Inc
16 Feb 24
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
4:03pm
employment other than due to his death, disability or for cause, then he will be entitled to a lump sum payment equal to 0.75 times the sum of (a) his annual
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
16 Feb 24
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
4:03pm
limitation, medical, prescription, dental, disability, employee life, group life, accidental death and travel accident insurance plans and programs … due to Disability (as defined below), (iii) a Termination for Cause (as defined below), (iv) the Termination Date specified in connection with any
8-K
dtup2gc
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
8-K
EX-10.1
3s9 1wtc7zme
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
8-K
6oegrskx0y
27 Nov 23
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
8:45am
8-K
EX-10.1
0loe759625q
27 Nov 23
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
8:45am
8-K
idir2b5l vagt
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
8-K
EX-10.1
prx0llmt
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm